Company profile
UK company 11680455, incorporated on 15 November 2018.
Rinri Therapeutics has been founded on research into regenerative cell therapy for hearing loss
Rinri Therapeutics has been founded on pioneering research into regenerative cell therapy led by Professor Marcelo Rivolta at the University of Sheffield.
Company number 11680455
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
Rinri Therapeutics develops therapeutics using stem cells to treat hearing disorders by replacing cells that are not working.
Although not a direct outcome of the this award, the spinout is related in the wider sense. Its purpose is to develop a treatment for hearing loss using human pluripotent stem cell derivatives
Commercial In Confidence
Company has progressed developing its pipeline porfolio, atracting new funding from investors
1 Aug 2025 to 30 Sep 2025
Allogeneic cell therapies - where a single donor-derived cell line is used to treat many patients - represent a transformative opportunity in modern medicine to address a wide range of conditions from cancer to neurological disorders. These therapies are often based on growing ('expanding') induced pluripotent stem cells (iPSCs) and then transforming ('di...
1 Apr 2021 to 31 Mar 2023
Over 400m people have disabling hearing loss in the world, with this figure expected to nearly double by 2050\. Deafness has a devastating effect on people, significantly affecting quality of life, education and employment prospects. The direct and indirect costs of hearing loss are estimated at £30B a year for the UK alone due to direct costs of life lon...
1 Jan 2021 to 31 Oct 2025
The World Health Organisation reports deafness as the second leading cause of years lived with disability. Half a billion people in the world have disabling hearing loss resulting in enormous personal, social and economic hardship. The current standard of care for hearing loss are hearing devices, including hearing aids and cochlear implants. However, the...
